AUS
NZ
UK
CA
USA
IND
Healthcare
Why Is Pro Medicus (ASX:PME) Testing Healthcare Stocks?
June 30, 2026 03:31 PM AEST| By SamASX healthcare stocks are facing a clinical validation test as regulatory progress, specialist technology and rare-disease updates place execution quality back in focus.
Why Is CSL (ASX:CSL) Central to Healthcare Rebound?
June 30, 2026 03:31 PM AEST| By SamASX healthcare stocks are being tested through quality rebound, with earnings confidence, clinical credibility and margin discipline shaping the latest market screen.
Why Is Pro Medicus (ASX:PME) Driving the Diagnostics Shift in ASX Healthcare Stocks?
June 30, 2026 03:31 PM AEST| By SamAustralia's healthcare sector is increasingly defined by diagnostics, medical imaging and workflow technology, with leading healthcare companies demonstrating how innovation and commercial execution continue reshaping industry attention.
Propel Funeral Partners (ASX:PFP): A Defensive ASX Dividend Stock Built for Uncertain Markets
June 29, 2026 12:44 PM AEST| By Sonal Goyal• PFP appears on a supplied ASX dividend screen with a trailing dividend yield of about 4.60% and an indicated yield of about 4.60%.
Epiminder (ASX:EPI): Cash Position Remains Under Market Spotlight
June 30, 2026 10:08 AM AEST| By SamEpiminder continues advancing its healthcare technology platform while maintaining financial flexibility, with cash management, product development and commercial execution remaining central to its long-term growth strategy.
CSL (ASX:CSL): Are AI Imaging Deals Changing Healthcare Valuations?
June 29, 2026 04:41 PM AEST| By SamASX healthcare stocks are being assessed through AI imaging partnerships, commercial channels, clinical progress and defensive earnings as medical technology becomes a sharper valuation signal.
Biotech Stocks: The Milestone Map Investors Are Reading Into July
June 29, 2026 04:40 PM AEST| By SamAustralia's healthcare sector is focusing on biotechnology milestones, commercial execution, medical technology adoption and defensive earnings as investors assess operational progress before the new financial year.
Pengana Private Equity Trust (ASX:PE1): Is This Private Equity Fund a Dividend Opportunity?
June 29, 2026 12:44 PM AEST| By Sonal Goyal• PE1 appears on a supplied ASX dividend screen with a trailing dividend yield of about 4.47% and an indicated yield of about 4.40%.
Why Is ResMed (ASX:RMD) Winning Back the ASX 200 Healthcare Story?
June 29, 2026 04:03 PM AEST| By SamResMed's latest quarterly performance highlighted stronger revenue growth and improving profitability, helping refocus attention on operational execution and the long-term demand for sleep healthcare solutions.
Why Is CSL (ASX:CSL) Facing Its Toughest Healthcare Test in Years?
June 29, 2026 04:02 PM AEST| By SamCSL has returned to focus as Australia's healthcare sector experiences broad weakness driven by changing market sentiment, sector rotation and renewed attention on defensive industries.
Why Is Cochlear (ASX:COH) Facing Its Biggest Challenge Yet?
June 29, 2026 04:02 PM AEST| By SamCochlear has reset earnings expectations following weaker procedure volumes and hospital constraints, while its long-term healthcare business continues to benefit from structural demand for hearing solutions.
Atlas Pearls (ASX:ATP) and Its 24% Dividend Yield: High Income or High Risk?
June 29, 2026 12:42 PM AEST| By Aditi Sarkar• Atlas Pearls (ASX:ATP) screens with a headline dividend yield of approximately 24.51%, making it one of the highest-yielding names on the ASX.
Neuren Pharmaceuticals (ASX:NEU) Draws Attention as Drug Pipeline Strengthens
June 29, 2026 10:06 AM AEST| By SamNeuren Pharmaceuticals continues advancing its rare disease pipeline as clinical development, licensing partnerships and regulatory progress remain key long-term business drivers.
Why Is Telix Pharmaceuticals (ASX:TLX) Standing Out This Year?
June 28, 2026 07:19 PM AEST| By SamTelix Pharmaceuticals, Lindian Resources and GemLife Communities showcase Australia's diverse growth landscape through healthcare innovation, rare earth development and specialised residential community expansion.
Why Is 4DMedical (ASX:4DX) Back in the Healthcare Spotlight?
June 28, 2026 04:03 PM AEST| By Sam4DMedical continues advancing its respiratory imaging technology through commercial expansion, healthcare innovation and growing clinical adoption across Australia and the United States.
Bapcor (ASX:BAP): Does a 23.29% Dividend Yield Signal Opportunity or a Dividend Trap?
June 29, 2026 12:42 PM AEST| By Aditi Sarkar• Bapcor (ASX:BAP) appeared on ASX dividend screens with a reported 23.29% trailing dividend yield.
Why ResMed (ASX:RMD) Is Rebuilding Confidence on the ASX 200?
June 26, 2026 07:57 PM AEST| By SamResMed continues demonstrating resilient healthcare demand through respiratory devices, digital health platforms and recurring revenue as market attention returns to its operating fundamentals.
Why Is CSL (ASX:CSL) Back on Healthcare Watchlists After Its Slide?
June 26, 2026 07:56 PM AEST| By SamCSL continues strengthening its healthcare business through a strategic reset, operational focus and ongoing leadership in plasma therapies as Australia's biotechnology sector attracts renewed market attention.
Why Is Cochlear (ASX:COH) Shaking the ASX 200 Healthcare Sector?
June 26, 2026 07:56 PM AEST| By SamCochlear's revised earnings outlook has renewed attention on Australia's healthcare sector as hospital constraints and softer patient demand reshape sentiment across medical technology companies.
G8 Education (ASX:GEM) 44% Dividend Yield: Bargain Income Stock or Screener Trap?
June 29, 2026 12:42 PM AEST| By Aditi Sarkar• G8 Education (ASX:GEM) appeared on an ASX dividend screener showing an unusually high 44% dividend yield.
Top ASX Healthcare Shares Back in Focus as Markets Waver
June 26, 2026 06:04 PM AEST| By SamASX healthcare stocks are attracting renewed attention as investors look toward sectors known for resilience during periods of market uncertainty.
Why Is Sigma Healthcare (ASX:SIG) Back in Focus Despite the Boots Exit?
June 26, 2026 12:08 PM AEST| By SamSigma Healthcare Ltd (ASX:SIG) remained in focus after outperforming the broader market alongside healthcare stocks.
Pro Medicus (ASX:PME) Joins Forces With EchoIQ—Could This Reshape Healthcare AI?
June 26, 2026 11:19 AM AEST| By SamPro Medicus has partnered with EchoIQ to strengthen artificial intelligence capabilities in cardiac imaging, reinforcing the growing importance of AI across healthcare diagnostics.
GQG Partners (ASX:GQG): Is the 15.20% Dividend Yield Sustainable for Income Investors?
June 29, 2026 12:42 PM AEST| By Aditi Sarkar• GQG Partners (ASX:GQG) appears on ASX dividend screens with a headline dividend yield of approximately 15.20%.
Pro Medicus (ASX:PME) Hunting for Its Next AI Deal? These ASX Healthcare Stocks Stand Out
June 26, 2026 11:17 AM AEST| By SamPro Medicus continues expanding its healthcare AI ecosystem, prompting attention on several ASX-listed medical technology companies operating across imaging, cardiology and diagnostic software.
4DMedical (ASX:4DX) Lands Key Approval—Can the Healthcare Rally Continue?
June 26, 2026 11:09 AM AEST| By Team Kalkine Media4DMedical has secured Australian regulatory approval for its CT:VQ imaging platform, marking an important commercial milestone as attention shifts towards adoption and reimbursement.
Advertise your brand on Kalkine Media